Compositions as adjuvants to improve immune responses to vaccines and methods of use
First Claim
1. A composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention provides compositions containing an antigen and a TIM targeting molecule. The invention additionally provides a TIM targeting molecule conjugate, for example, a TIM targeting molecule targeted to a therapeutic or diagnostic moiety. The invention additionally provides methods of using such compositions. In one embodiment, the invention provides a method of stimulating an immune response in an individual by administering a composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier. In another embodiment, the invention provides a method of stimulating an immune response in an individual by administering an antigen and a TIM targeting molecule, which can be administered together in a single composition or separately.
-
Citations
122 Claims
- 1. A composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier.
- 9. A composition comprising a TIM targeting molecule conjugated to a therapeutic or diagnostic moiety.
- 23. A method of stimulating an immune response in an individual, comprising administering a composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier.
- 30. A method of prophylactic treatment of a disease, comprising administering to an individual a composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier.
- 39. A method of ameliorating a sign or symptom associated with a disease, comprising administering to an individual a composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier.
- 48. A method of targeting a tumor, comprising administering a TIM targeting molecule to a subject, wherein said tumor expresses a TIM or TIM ligand.
- 72. A method of inhibiting tumor growth, comprising administering a TIM targeting molecule to a subject, wherein said tumor expresses a TIM or TIM ligand.
- 95. A method of detecting a tumor, comprising administering a TIM targeting molecule conjugated to a diagnostic moiety to a subject, wherein said tumor expresses a TIM or TIM ligand.
- 100. A method of ameliorating a sign or symptom associated with an autoimmune disease, comprising administering a TIM targeting molecule to a subject.
Specification